WDL
EW icon

Well Done LLC’s Edwards Lifesciences EW Stock Holding History

Well Done LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,057
Closed -$156K – 312
2018
Q4 		$156K Buy
+3,057
New +$155K 0.04% 157
2018
Q2 		– Sell
-3,270
Closed -$152K – 247
2018
Q1 		$152K Buy
+3,270
New +$142K 0.05% 126
2017
Q4 		– Sell
-29,094
Closed -$1.06M – 128
2017
Q3 		$1.06M Buy
+29,094
New +$1.11M 0.33% 50

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Well Done LLC's EW Position: Q1 2019 in Review

Well Done LLC sold out of Edwards Lifesciences (EW) in Q1 2019, closing a stake of 3,057 shares — an estimated $156K sold.

Well Done LLC first reported a position in EW in Q3 2017 and held it in 3 quarters. The position peaked at $1.06M in Q3 2017. 923 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • Well Done LLC reported no remaining Edwards Lifesciences position as of Q1 2019 after selling out during the quarter.
  • Well Done LLC sold 3,057 Edwards Lifesciences shares in Q1 2019, an estimated $156K.
  • Well Done LLC first reported a position in Edwards Lifesciences in Q3 2017 and held it in 3 quarters.
  • Well Done LLC's Edwards Lifesciences position peaked at $1.06M in Q3 2017.
  • 923 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.